Skip to main content
. 2021 Dec 27;13(3):394–403. doi: 10.1111/1759-7714.14271

FIGURE 3.

FIGURE 3

Subgroup analysis of PFS between patients in the IO+C and C groups. (a) Age ≤ 65 subgroup. (b) Liver metastasis subgroup. (c) Adrenal metastasis subgroup. (d) Third‐line treatment subgroup